Jan 29, 2025 · Repeated brain injury quickens ALS onset and progression in mice. Repeated traumatic brain injuries (TBIs), which happen when the brain is damaged by external impacts …

Jan 8, 2025 · The number of people living with amyotrophic lateral sclerosis (ALS) in the U.S. is expected to steadily climb — by more than 10% — over this decade, increasing from an …

Dec 30, 2024 · Read this story here. No. 8 – COYA 302 immune-modulating therapy shows promise in small early trial. Coya Therapeutics’ investigational therapy COYA 302 was found …

Jan 3, 2025 · That’s according to the study, “ Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case …

Mar 4, 2024 · The new data comes from the PARADIGM Phase 2b study (NCT05357950), a fully enrolled clinical trial that’s testing oral PrimeC against a placebo in 68 adults with ALS. …

Mar 8, 2023 · Other types of ALS Juvenile ALS. In most people, ALS develops in middle or late adulthood. Juvenile ALS, meanwhile, refers to disease that develops in patients younger than …

Nov 22, 2024 · The upcoming trial intends to investigate the safety and effectiveness of two foralumab doses in 20 ALS patients. It builds on positive findings from multiple sclerosis (MS) …

Oct 17, 2024 · The Scott-Morgan Foundation (SMF), a nonprofit that’s pioneering assistive technology innovation, will lead a new initiative using artificial intelligence (AI) technologies to …

Oct 29, 2024 · Developed under a collaboration between the nonprofit Target ALS and Zephyrx, the database features respiratory function data collected remotely and over time using …

Dec 19, 2024 · In PARADIGM (NCT05357950), a completed Phase 2b study, PrimeC was tested against a placebo, both taken as two tablets by mouth twice daily for six months, in 68 adults …